Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
Channing J Paller, Emmanuel S AntonarakisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, USAAbstract: Until recently, patients with castration-resistant prostate cancer (CRPC) had limited therapeutic options once they became refractory to docetaxel chemotherapy, and no treat...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2011-03-01
|
| Serie: | Drug Design, Development and Therapy |
| Accesso online: | http://www.dovepress.com/cabazitaxel-a-novel-second-line-treatment-for-metastatic-castration-re-a6627 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|